Product Program year 2025 Source: CMS Open Payments

Focal One

Device Prostate Cancer

PDI 03661690000052

Open in the dashboard

General payments

$762,952

1,074 payments

Research payments

$0

0 payments

Through program year 2025, $762,952 in general payments and $0 in research payments were reported against Focal One (Prostate Cancer).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $762,952 1,074

Breakdown

Who paid General payments · program year 2025
  1. Edap Technomed Inc $762,952 1,074 payments
Top recipients General payments · program year 2025
  1. Kyrollis Attalla Urology · New York, NY $202,878 27% · 70 payments
  2. Amir Lebastchi Urology · Los Angeles, CA $133,631 18% · 53 payments
  3. Cary Robertson Urology · Durham, NC $33,301 4% · 15 payments
  4. Alexander Cole Urology · Boston, MA $25,143 3% · 8 payments
  5. Alon Lazarovich Urology · Chicago, IL $19,559 3% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $728,398 97% · 358 practitioners
  2. Physician Assistant, Surgical Physician Assistant $14,123 2% · 5 practitioners
  3. Anatomic Pathology & Clinical Pathology Pathology $1,500 <1% · 1 practitioner
  4. Diagnostic Radiology Radiology $1,363 <1% · 4 practitioners
  5. Physician Assistant $1,091 <1% · 21 practitioners

The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $265,868 35% · 50 recipients
  2. California $237,949 31% · 73 recipients
  3. North Carolina $34,370 5% · 8 recipients
  4. New Jersey $32,623 4% · 54 recipients
  5. Florida $31,884 4% · 61 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,074 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record